Background and Objectives: To determine the survival benefits of additional adjuvant
hysterectomy in the International Federation of Gynecology and Obstetrics (FIGO) stage I‐II …

Objective To evaluate the prognostic influence of adenocarcinoma (AC) and
adenosquamous carcinoma (ASC) in patients with FIGO stage IB–IIA cervical cancer who …

Background We evaluated the survival effect of adjuvant concurrent chemoradiotherapy
after radical hysterectomy in patients with clinical pelvic node-positive cervical …

Objectives To evaluate the significance of adenosquamous carcinoma (ASC) compared with
adenocarcinoma (AC) in the survival of surgically treated early-stage cervical cancer …

The efficacy of radiotherapy (RT) for adenocarcinoma (AC) is controversial, although
patients with AC of the uterine cervix are treated in a similar manner to those with squamous …

Background To assess the survival outcomes in patients with International Federation of
Gynecology and Obstetrics (FIGO) stage I–IIA adenocarcinoma (AC) or squamous cell …

Objective: To compare patient survival outcomes between completion hysterectomy and
conventional surveillance in locally advanced adenocarcinoma of the cervix after concurrent …

OBJECTIVES: The aim of this study was to compare the treatment outcomes and adverse
effects of radical hysterectomy followed by adjuvant radiotherapy with definitive radiotherapy …

Objective: To compare treatment outcome of conventional surgery followed by adjuvant
postoperative radiotherapy (PORT) versus concurrent chemoradiation therapy (cCRT) for …

Objective Adjuvant hysterectomy following chemoradiation (CRT) is a treatment option used
worldwide for early-stage cervical cancer but the benefit of hysterectomy in this setting is …